IFP Advisors’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$184K Sell
148,330
-45,950
-24% -$57K 0.01% 1307
2025
Q1
$229K Sell
194,280
-7,305
-4% -$8.62K 0.01% 1112
2024
Q4
$369K Buy
201,585
+38,984
+24% +$71.3K 0.01% 861
2024
Q3
$276K Buy
162,601
+161,601
+16,160% +$275K 0.01% 933
2024
Q2
$1.37K Hold
1,000
﹤0.01% 2910
2024
Q1
$3.75K Hold
1,000
﹤0.01% 2534
2023
Q4
$9.81K Hold
1,000
﹤0.01% 2193
2023
Q3
$8.35K Sell
1,000
-250
-20% -$2.09K ﹤0.01% 2326
2023
Q2
$16.6K Hold
1,250
﹤0.01% 2100
2023
Q1
$3.26K Sell
1,250
-1,600
-56% -$4.18K ﹤0.01% 2734
2022
Q4
$8K Sell
2,850
-300
-10% -$842 ﹤0.01% 3543
2022
Q3
$9K Hold
3,150
﹤0.01% 3725
2022
Q2
$9K Hold
3,150
﹤0.01% 3477
2022
Q1
$9K Hold
3,150
﹤0.01% 3477
2021
Q4
$63K Sell
3,150
-450
-13% -$9K ﹤0.01% 1452
2021
Q3
$92K Buy
3,600
+50
+1% +$1.28K ﹤0.01% 1290
2021
Q2
$124K Buy
3,550
+500
+16% +$17.5K ﹤0.01% 1136
2021
Q1
$102K Sell
3,050
-7,950
-72% -$266K ﹤0.01% 1169
2020
Q4
$286K Buy
11,000
+1,000
+10% +$26K 0.01% 678
2020
Q3
$99K Buy
10,000
+5,000
+100% +$49.5K 0.01% 1004
2020
Q2
$17K Sell
5,000
-37
-0.7% -$126 ﹤0.01% 1609
2020
Q1
$18K Buy
5,037
+5,000
+13,514% +$17.9K ﹤0.01% 1527
2019
Q4
$0 Sell
37
-200
-84% ﹤0.01% 3383
2019
Q3
$1K Buy
+237
New +$1K ﹤0.01% 2889
2019
Q1
$108K Sell
15,000
-8,196
-35% -$59K 0.01% 663
2018
Q4
$170K Sell
23,196
-17,693
-43% -$130K 0.01% 924
2018
Q3
$221K Buy
40,889
+1,050
+3% +$5.68K 0.01% 1020
2018
Q2
$141K Sell
39,839
-16,945
-30% -$60K 0.01% 1276
2018
Q1
$150K Hold
56,784
0.01% 1131
2017
Q4
$150K Sell
56,784
-450
-0.8% -$1.19K 0.01% 1128
2017
Q3
$300K Sell
57,234
-550
-1% -$2.88K 0.01% 921
2017
Q2
$206K Sell
57,784
-10,398
-15% -$37.1K 0.01% 1109
2017
Q1
$353K Sell
68,182
-16,560
-20% -$85.7K 0.02% 839
2016
Q4
$322K Sell
84,742
-33,705
-28% -$128K 0.02% 822
2016
Q3
$1.06M Sell
118,447
-850
-0.7% -$7.61K 0.06% 344
2016
Q2
$839K Buy
119,297
+104,297
+695% +$734K 0.05% 386
2016
Q1
$108K Sell
15,000
-37,236
-71% -$268K 0.01% 663
2015
Q4
$686K Buy
+52,236
New +$686K 0.05% 400